Financhill
Back

Abbott Laboratories Quote, Financials, Valuation and Earnings

Prepare now for a ChatGPT IPO announcement

Click here to see more
Sell
47

ABT
Abbott Laboratories

Last Price:
102.82
Seasonality Move:
3.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Is Elon Musk right about AI?

Learn all about it here.

Abbott Laboratories Price Quote

$102.82
-0.03 (-0.08%)
(Updated: September 2, 2023 at 5:57 AM ET)

Abbott Laboratories Key Stats

Sell
47
Abbott Laboratories (ABT) is a Sell

Day range:
$102.56 - $103.79
52-week range:
$93.25 - $115.83
Dividend yield:
1.95%
P/E ratio:
26.30
P/S ratio:
4.49
P/B ratio:
4.8%

Volume:
2.6M
Avg. volume:
4.2M
1-year change:
-1.9%
Market cap:
$178.5B
Revenue:
$43.7B
EPS:
$2.93

How Much Does Abbott Laboratories Make?

Is Abbott Laboratories Growing As A Company?

  • What Is Abbott Laboratories's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.11%
  • What Is Abbott Laboratories's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.32%

Abbott Laboratories Stock Price Performance

What Is Abbott Laboratories 52-Week High & Low?

Abbott Laboratories Price To Free Cash Flow

Is It Risky To Buy Abbott Laboratories?

Is Abbott Laboratories Cash Flow Positive?

  • What Is ABT Cash Flow From Operations?
    Cash flow from operations (TTM) is $7.5B
  • What Is Abbott Laboratories’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.7B
  • What Is Abbott Laboratories’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.8B

Abbott Laboratories Return On Invested Capital

  • Is Management Doing A Good Job?
    ABT return on invested capital is 9.64%
  • What Is Abbott Laboratories Return On Assets?
    ROA measures how assets are converting to revenues and is 7%
  • What Is ABT Return On Equity?
    ROE is a measure of profitability and is 14.1%

Abbott Laboratories Earnings Date & Stock Price

Abbott Laboratories Competitors

Abbott Laboratories Dividend Yield

Abbott Laboratories Analyst Estimates

YoY Growth Past Surprise
EPS: -31.58% 2.89%
Revenue: -11.36% 2.7%

Analyst Recommendations

Buy Recommendations: 12
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 123.77
Upside from Last Price: 20.34%

Major Shareholders

  • How many ABT shares are owned by institutional investors?
    2.1B ABT shares are owned by institutional investors
  • How many ABT shares are owned by insiders?
    15.1M ABT shares are owned by insiders